NEOPLASMS, URETHRAL

Clinical trials for NEOPLASMS, URETHRAL explained in plain language.

Never miss a new study

Get alerted when new NEOPLASMS, URETHRAL trials appear

Sign up with your email to follow new studies for NEOPLASMS, URETHRAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

First test of new cancer drug mix for Tough-to-Treat tumors

Disease control Completed

This early-stage study aimed to find the safest and most effective dose of a three-drug combination (gemcitabine, carboplatin, and lenalidomide) for people with advanced solid tumors, especially bladder cancer, that had not responded to standard treatments. It involved 18 adults …

Matched conditions: NEOPLASMS, URETHRAL

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

NEOPLASMS, URETHRAL

Get alerted when new NEOPLASMS, URETHRAL trials appear

First test of new cancer drug mix for Tough-to-Treat tumors